DBV Technologies S.A. (DBVT)
DBV Technologies S.A. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
DBV Technologies S.A. (DBVT) is a Biotechnology company based in FR with a market capitalization of $340.2M. Free cash flow was negative at -$121.7M. This page tracks DBVT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
FR · 106 employees · IPO Oct 22, 2014
Valuation
Valuation & price
$18.32as of May 26, 2026· -25.3% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
2.02
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$340.2M
Market cap
—
Revenue growth (YoY)
100.0%
Gross margin
-$121.7M
Free cash flow (USD)
-$172.5M
Net debt
Net cash position
-10.2%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2023
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: Jul 16, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 16, 2026Filing
Earnings Release
- Quarterly reportJul 16, 2026Filing
10-Q Filed
- 8-K eventJun 29, 2026Filing
BLA Submission Update
- 8-K eventJun 5, 2026Filing
Performance Share Unit Plan
- 8-K eventJun 3, 2026Filing
Bylaw Amendments and Shareholder Meeting
- 8-K eventMay 5, 2026Filing
Performance Share Unit Plan
- Annual reportApr 30, 2026Filing
10-K Filed
- Quarterly reportApr 30, 2026Filing
10-Q Filed
- 8-K eventApr 30, 2026Filing
Earnings Release
Questions
Frequently asked questions
What is DBV Technologies S.A.'s market cap?
DBV Technologies S.A. (DBVT) has a market capitalization of $340.2M.
What is DBVT's P/E ratio?
A meaningful P/E ratio is not available for DBVT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is DBVT's price-to-book (P/B) ratio?
DBVT trades at 2.02 times book value per share.
When did DBV Technologies S.A. last report earnings?
DBVT last reported earnings on July 16, 2026; the next date is not yet scheduled.
Are insiders buying DBVT stock?
SEC Form 4 filings show no open-market insider buys at DBV Technologies S.A. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.